LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 288

Search options

  1. Article ; Online: Formalin: a formaldehyde analogue.

    Cheung, Amanda F P / Lam, Dennis S C

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

    2017  Volume 52, Issue 2, Page(s) 229

    MeSH term(s) Formaldehyde
    Chemical Substances Formaldehyde (1HG84L3525)
    Language English
    Publishing date 2017
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 80091-0
    ISSN 1715-3360 ; 0008-4182
    ISSN (online) 1715-3360
    ISSN 0008-4182
    DOI 10.1016/j.jcjo.2017.02.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Case Report: Primary Thoracic Low-Grade Fibromyxoid Sarcoma in a Young Girl Presenting With Mediastinal Mass Syndrome.

    Chan, Yat Chi / Kan, Amanda N C / Yuen, Liz Y P / Wan, Innes Y P / Fung, Kevin K F / Cheung, Yiu-Fai / Leung, Karen K Y / Ku, Dennis T L / Liu, Anthony P Y

    Frontiers in pediatrics

    2022  Volume 10, Page(s) 885068

    Abstract: Low-grade fibromyxoid sarcomas (LGFMSs) are typically adult-onset tumors that arise from the extremities. Here, we report an exceptional case of primary thoracic LGFMS in an 8-year-old girl that resulted in mediastinal syndrome. In reporting this case, ... ...

    Abstract Low-grade fibromyxoid sarcomas (LGFMSs) are typically adult-onset tumors that arise from the extremities. Here, we report an exceptional case of primary thoracic LGFMS in an 8-year-old girl that resulted in mediastinal syndrome. In reporting this case, we discuss the clinical challenges, role of molecular profiling and review reported cases of pediatric thoracic LGFMSs.
    Language English
    Publishing date 2022-06-17
    Publishing country Switzerland
    Document type Case Reports
    ZDB-ID 2711999-3
    ISSN 2296-2360
    ISSN 2296-2360
    DOI 10.3389/fped.2022.885068
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Patient randomised controlled trial of technology enabled strategies to promote treatment adherence in liver transplantation: rationale and design of the TEST trial.

    Serper, Marina / Burdzy, Alexander / Schaubel, Douglas E / Mason, Richard / Banerjee, Arpita / Goldberg, David S / Martin, Eric F / Mehta, Shivan J / Russell, Louise B / Cheung, Amanda C / Ladner, Daniela P / Yoshino Benavente, Julia / Wolf, Michael S

    BMJ open

    2023  Volume 13, Issue 9, Page(s) e075172

    Abstract: Background and aims: Liver transplantation is a life-saving procedure for end-stage liver disease. However, post-transplant medication regimens are complex and non-adherence is common. Post-transplant medication non-adherence is associated with graft ... ...

    Abstract Background and aims: Liver transplantation is a life-saving procedure for end-stage liver disease. However, post-transplant medication regimens are complex and non-adherence is common. Post-transplant medication non-adherence is associated with graft rejection, which can have long-term adverse consequences. Transplant centres are equipped with clinical staff that monitor patients post-transplant; however, digital health tools and proactive immunosuppression adherence monitoring has potential to improve outcomes.
    Methods and analysis: This is a patient-randomised prospective clinical trial at three transplant centres in the Northeast, Midwest and South to investigate the effects of a remotely administered adherence programme compared with usual care. The programme monitors potential non-adherence largely levering text message prompts and phenotypes the nature of the non-adhere as cognitive, psychological, medical, social or economic. Additional reminders for medications, clinical appointments and routine self-management support are incorporated to promote adherence to the entire medical regimen. The primary study outcome is medication adherence via 24-hour recall; secondary outcomes include additional medication adherence (ASK-12 self-reported scale, regimen knowledge scales, tacrolimus values), quality of life, functional health status and clinical outcomes (eg, days hospitalised). Study implementation, acceptability, feasibility, costs and potential cost-effectiveness will also be evaluated.
    Ethics and dissemination: The University of Pennsylvania Review Board has approved the study as the single IRB of record (protocol # 849575, V.1.4). Results will be published in peer-reviewed journals and summaries will be provided to study funders.
    Trial registration number: NCT05260268.
    MeSH term(s) Humans ; Liver Transplantation ; Prospective Studies ; Quality of Life ; Treatment Adherence and Compliance ; End Stage Liver Disease
    Language English
    Publishing date 2023-09-18
    Publishing country England
    Document type Randomized Controlled Trial ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2023-075172
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients With Large Ischemic Strokes: A Prespecified Analysis of the SELECT2 Trial.

    Sarraj, Amrou / Hill, Michael D / Hussain, M Shazam / Abraham, Michael G / Ortega-Gutierrez, Santiago / Chen, Michael / Kasner, Scott E / Churilov, Leonid / Pujara, Deep K / Johns, Hannah / Blackburn, Spiros / Sundararajan, Sophia / Hu, Yin C / Herial, Nabeel A / Budzik, Ronald F / Hicks, William J / Arenillas, Juan F / Tsai, Jenny P / Kozak, Osman /
    Cordato, Dennis J / Hanel, Ricardo A / Wu, Teddy Y / Portela, Pere Cardona / Gandhi, Chirag D / Al-Mufti, Fawaz / Maali, Laith / Gibson, Daniel / Pérez de la Ossa, Natalia / Schaafsma, Joanna D / Blasco, Jordi / Sangha, Navdeep / Warach, Steven / Kleinig, Timothy J / Shaker, Faris / Sitton, Clark W / Nguyen, Thanh / Fifi, Johanna T / Jabbour, Pascal / Furlan, Anthony / Lansberg, Maarten G / Tsivgoulis, Georgios / Sila, Cathy / Bambakidis, Nicholas / Davis, Stephen / Wechsler, Lawrence / Albers, Greg W / Grotta, James C / Ribo, Marc / Campbell, Bruce C / Hassan, Ameer E / Vora, Nirav / Manning, Nathan W / Cheung, Andrew / Aghaebrahim, Amin N / Paipa Merchán, Andres J / Sahlein, Daniel / Requena Ruiz, Manuel / Elijovich, Lucas / Arthur, Adam / Al-Shaibi, Faisal / Samaniego, Edgar A / Duncan, Kelsey R / Opaskar, Amanda / Ray, Abhishek / Xiong, Wei / Sunshine, Jeffery / DeGeorgia, Michael / Tjoumakaris, Stavropoula / Mendes Pereira, Vitor

    JAMA neurology

    2024  

    Abstract: ... 11-2.03) without heterogeneity (P for interaction = .14). Treatment effect point estimates favored ...

    Abstract Importance: Patients with large ischemic core stroke have poor clinical outcomes and are frequently not considered for interfacility transfer for endovascular thrombectomy (EVT).
    Objective: To assess EVT treatment effects in transferred vs directly presenting patients and to evaluate the association between transfer times and neuroimaging changes with EVT clinical outcomes.
    Design, setting, and participants: This prespecified secondary analysis of the SELECT2 trial, which evaluated EVT vs medical management (MM) in patients with large ischemic stroke, evaluated adults aged 18 to 85 years with acute ischemic stroke due to occlusion of the internal carotid or middle cerebral artery (M1 segment) as well as an Alberta Stroke Program Early CT Score (ASPECTS) of 3 to 5, core of 50 mL or greater on imaging, or both. Patients were enrolled between October 2019 and September 2022 from 31 EVT-capable centers in the US, Canada, Europe, Australia, and New Zealand. Data were analyzed from August 2023 to January 2024.
    Interventions: EVT vs MM.
    Main outcomes and measures: Functional outcome, defined as modified Rankin Scale (mRS) score at 90 days with blinded adjudication.
    Results: A total of 958 patients were screened and 606 patients were excluded. Of 352 enrolled patients, 145 (41.2%) were female, and the median (IQR) age was 66.5 (58-75) years. A total of 211 patients (59.9%) were transfers, while 141 (40.1%) presented directly. The median (IQR) transfer time was 178 (136-230) minutes. The median (IQR) ASPECTS decreased from the referring hospital (5 [4-7]) to an EVT-capable center (4 [3-5]). Thrombectomy treatment effect was observed in both directly presenting patients (adjusted generalized odds ratio [OR], 2.01; 95% CI, 1.42-2.86) and transferred patients (adjusted generalized OR, 1.50; 95% CI, 1.11-2.03) without heterogeneity (P for interaction = .14). Treatment effect point estimates favored EVT among 82 transferred patients with a referral hospital ASPECTS of 5 or less (44 received EVT; adjusted generalized OR, 1.52; 95% CI, 0.89-2.58). ASPECTS loss was associated with numerically worse EVT outcomes (adjusted generalized OR per 1-ASPECTS point loss, 0.89; 95% CI, 0.77-1.02). EVT treatment effect estimates were lower in patients with transfer times of 3 hours or more (adjusted generalized OR, 1.15; 95% CI, 0.73-1.80).
    Conclusions and relevance: Both directly presenting and transferred patients with large ischemic stroke in the SELECT2 trial benefited from EVT, including those with low ASPECTS at referring hospitals. However, the association of EVT with better functional outcomes was numerically better in patients presenting directly to EVT-capable centers. Prolonged transfer times and evolution of ischemic change were associated with worse EVT outcomes. These findings emphasize the need for rapid identification of patients suitable for transfer and expedited transport.
    Trial registration: ClinicalTrials.gov Identifier: NCT03876457.
    Language English
    Publishing date 2024-02-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2702023-X
    ISSN 2168-6157 ; 2168-6149
    ISSN (online) 2168-6157
    ISSN 2168-6149
    DOI 10.1001/jamaneurol.2024.0206
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance.

    Ottilie, Sabine / Luth, Madeline R / Hellemann, Erich / Goldgof, Gregory M / Vigil, Eddy / Kumar, Prianka / Cheung, Andrea L / Song, Miranda / Godinez-Macias, Karla P / Carolino, Krypton / Yang, Jennifer / Lopez, Gisel / Abraham, Matthew / Tarsio, Maureen / LeBlanc, Emmanuelle / Whitesell, Luke / Schenken, Jake / Gunawan, Felicia / Patel, Reysha /
    Smith, Joshua / Love, Melissa S / Williams, Roy M / McNamara, Case W / Gerwick, William H / Ideker, Trey / Suzuki, Yo / Wirth, Dyann F / Lukens, Amanda K / Kane, Patricia M / Cowen, Leah E / Durrant, Jacob D / Winzeler, Elizabeth A

    Communications biology

    2022  Volume 5, Issue 1, Page(s) 128

    Abstract: In vitro evolution and whole genome analysis were used to comprehensively identify the genetic determinants of chemical resistance in Saccharomyces cerevisiae. Sequence analysis identified many genes contributing to the resistance phenotype as well as ... ...

    Abstract In vitro evolution and whole genome analysis were used to comprehensively identify the genetic determinants of chemical resistance in Saccharomyces cerevisiae. Sequence analysis identified many genes contributing to the resistance phenotype as well as numerous amino acids in potential targets that may play a role in compound binding. Our work shows that compound-target pairs can be conserved across multiple species. The set of 25 most frequently mutated genes was enriched for transcription factors, and for almost 25 percent of the compounds, resistance was mediated by one of 100 independently derived, gain-of-function SNVs found in a 170 amino acid domain in the two Zn
    MeSH term(s) Gene Expression Regulation, Fungal ; Saccharomyces cerevisiae/genetics ; Saccharomyces cerevisiae/metabolism ; Saccharomyces cerevisiae Proteins/genetics ; Saccharomyces cerevisiae Proteins/metabolism ; Transcription Factors/metabolism ; Xenobiotics/metabolism ; Xenobiotics/pharmacology
    Chemical Substances Saccharomyces cerevisiae Proteins ; Transcription Factors ; Xenobiotics
    Language English
    Publishing date 2022-02-11
    Publishing country England
    Document type Journal Article
    ISSN 2399-3642
    ISSN (online) 2399-3642
    DOI 10.1038/s42003-022-03076-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance

    Sabine Ottilie / Madeline R. Luth / Erich Hellemann / Gregory M. Goldgof / Eddy Vigil / Prianka Kumar / Andrea L. Cheung / Miranda Song / Karla P. Godinez-Macias / Krypton Carolino / Jennifer Yang / Gisel Lopez / Matthew Abraham / Maureen Tarsio / Emmanuelle LeBlanc / Luke Whitesell / Jake Schenken / Felicia Gunawan / Reysha Patel /
    Joshua Smith / Melissa S. Love / Roy M. Williams / Case W. McNamara / William H. Gerwick / Trey Ideker / Yo Suzuki / Dyann F. Wirth / Amanda K. Lukens / Patricia M. Kane / Leah E. Cowen / Jacob D. Durrant / Elizabeth A. Winzeler

    Communications Biology, Vol 5, Iss 1, Pp 1-

    2022  Volume 14

    Abstract: Ottilie et al. employ an experimental evolution approach to investigate the role of transcription factors in yeast chemical resistance. Most emergent mutations in resistant strains were enriched in transcription factor coding genes, highlighting their ... ...

    Abstract Ottilie et al. employ an experimental evolution approach to investigate the role of transcription factors in yeast chemical resistance. Most emergent mutations in resistant strains were enriched in transcription factor coding genes, highlighting their importance in drug resistance.
    Keywords Biology (General) ; QH301-705.5
    Language English
    Publishing date 2022-02-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year period.

    Woo, Peter Y M / Yau, Stephen / Lam, Tai-Chung / Pu, Jenny K S / Li, Lai-Fung / Lui, Louisa C Y / Chan, Danny T M / Loong, Herbert H F / Lee, Michael W Y / Yeung, Rebecca / Kwok, Carol C H / Au, Siu-Kie / Tan, Tze-Ching / Kan, Amanda N C / Chan, Tony K T / Mak, Calvin H K / Mak, Henry K F / Ho, Jason M K / Cheung, Ka-Man /
    Tse, Teresa P K / Lau, Sarah S N / Chow, Joyce S W / El-Helali, Aya / Ng, Ho-Keung / Poon, Wai-Sang

    Neuro-oncology practice

    2022  Volume 10, Issue 1, Page(s) 50–61

    Abstract: Background: The aim of this study is to address the paucity of epidemiological data regarding the characteristics, treatment patterns and survival outcomes of Chinese glioblastoma patients.: Methods: This was a population-level study of Hong Kong ... ...

    Abstract Background: The aim of this study is to address the paucity of epidemiological data regarding the characteristics, treatment patterns and survival outcomes of Chinese glioblastoma patients.
    Methods: This was a population-level study of Hong Kong adult (
    Results: One thousand and ten patients with a median follow-up of 10.0 months were reviewed. The ASIR of glioblastoma was 1.0 per 100 000 population with no significant change during the study period. The mean age was 57
    Conclusions: The incidence of glioblastoma in the Chinese general population is low. We charted the development of neuro-oncological care of glioblastoma patients in Hong Kong during the temozolomide era. Although there was an increased adoption of temozolomide chemoradiotherapy, a corresponding improvement in survival was not observed.
    Language English
    Publishing date 2022-09-10
    Publishing country England
    Document type Journal Article
    ZDB-ID 2768945-1
    ISSN 2054-2585 ; 2054-2577
    ISSN (online) 2054-2585
    ISSN 2054-2577
    DOI 10.1093/nop/npac069
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Endovascular Thrombectomy for Large Ischemic Stroke Across Ischemic Injury and Penumbra Profiles.

    Sarraj, Amrou / Hassan, Ameer E / Abraham, Michael G / Ortega-Gutierrez, Santiago / Kasner, Scott E / Hussain, Muhammad Shazam / Chen, Michael / Churilov, Leonid / Johns, Hannah / Sitton, Clark W / Yogendrakumar, Vignan / Ng, Felix C / Pujara, Deep K / Blackburn, Spiros / Sundararajan, Sophia / Hu, Yin C / Herial, Nabeel A / Arenillas, Juan F / Tsai, Jenny P /
    Budzik, Ronald F / Hicks, William J / Kozak, Osman / Yan, Bernard / Cordato, Dennis J / Manning, Nathan W / Parsons, Mark W / Cheung, Andrew / Hanel, Ricardo A / Aghaebrahim, Amin N / Wu, Teddy Y / Portela, Pere Cardona / Gandhi, Chirag D / Al-Mufti, Fawaz / Pérez de la Ossa, Natalia / Schaafsma, Joanna D / Blasco, Jordi / Sangha, Navdeep / Warach, Steven / Kleinig, Timothy J / Shaker, Faris / Al Shaibi, Faisal / Toth, Gabor / Abdulrazzak, Mohammad A / Sharma, Gagan / Ray, Abhishek / Sunshine, Jeffrey / Opaskar, Amanda / Duncan, Kelsey R / Xiong, Wei / Samaniego, Edgar A / Maali, Laith / Lechtenberg, Colleen G / Renú, Arturo / Vora, Nirav / Nguyen, Thanh / Fifi, Johanna T / Tjoumakaris, Stavropoula I / Jabbour, Pascal / Tsivgoulis, Georgios / Pereira, Vitor Mendes / Lansberg, Maarten G / DeGeorgia, Michael / Sila, Cathy A / Bambakidis, Nicholas / Hill, Michael D / Davis, Stephen M / Wechsler, Lawrence / Grotta, James C / Ribo, Marc / Albers, Greg W / Campbell, Bruce C

    JAMA

    2024  Volume 331, Issue 9, Page(s) 750–763

    Abstract: Importance: Whether endovascular thrombectomy (EVT) efficacy for patients with acute ischemic stroke and large cores varies depending on the extent of ischemic injury is uncertain.: Objective: To describe the relationship between imaging estimates of ...

    Abstract Importance: Whether endovascular thrombectomy (EVT) efficacy for patients with acute ischemic stroke and large cores varies depending on the extent of ischemic injury is uncertain.
    Objective: To describe the relationship between imaging estimates of irreversibly injured brain (core) and at-risk regions (mismatch) and clinical outcomes and EVT treatment effect.
    Design, setting, and participants: An exploratory analysis of the SELECT2 trial, which randomized 352 adults (18-85 years) with acute ischemic stroke due to occlusion of the internal carotid or middle cerebral artery (M1 segment) and large ischemic core to EVT vs medical management (MM), across 31 global centers between October 2019 and September 2022.
    Intervention: EVT vs MM.
    Main outcomes and measures: Primary outcome was functional outcome-90-day mRS score (0, no symptoms, to 6, death) assessed by adjusted generalized OR (aGenOR; values >1 represent more favorable outcomes). Benefit of EVT vs MM was assessed across levels of ischemic injury defined by noncontrast CT using ASPECTS score and by the volume of brain with severely reduced blood flow on CT perfusion or restricted diffusion on MRI.
    Results: Among 352 patients randomized, 336 were analyzed (median age, 67 years; 139 [41.4%] female); of these, 168 (50%) were randomized to EVT, and 2 additional crossover MM patients received EVT. In an ordinal analysis of mRS at 90 days, EVT improved functional outcomes compared with MM within ASPECTS categories of 3 (aGenOR, 1.71 [95% CI, 1.04-2.81]), 4 (aGenOR, 2.01 [95% CI, 1.19-3.40]), and 5 (aGenOR, 1.85 [95% CI, 1.22-2.79]). Across strata for CT perfusion/MRI ischemic core volumes, aGenOR for EVT vs MM was 1.63 (95% CI, 1.23-2.16) for volumes ≥70 mL, 1.41 (95% CI, 0.99-2.02) for ≥100 mL, and 1.47 (95% CI, 0.84-2.56) for ≥150 mL. In the EVT group, outcomes worsened as ASPECTS decreased (aGenOR, 0.91 [95% CI, 0.82-1.00] per 1-point decrease) and as CT perfusion/MRI ischemic core volume increased (aGenOR, 0.92 [95% CI, 0.89-0.95] per 10-mL increase). No heterogeneity of EVT treatment effect was observed with or without mismatch, although few patients without mismatch were enrolled.
    Conclusion and relevance: In this exploratory analysis of a randomized clinical trial of patients with extensive ischemic stroke, EVT improved clinical outcomes across a wide spectrum of infarct volumes, although enrollment of patients with minimal penumbra volume was low. In EVT-treated patients, clinical outcomes worsened as presenting ischemic injury estimates increased.
    Trial registration: ClinicalTrials.gov Identifier: NCT03876457.
    MeSH term(s) Adult ; Humans ; Female ; Aged ; Male ; Stroke/diagnostic imaging ; Stroke/surgery ; Ischemic Stroke/diagnostic imaging ; Ischemic Stroke/surgery ; Brain Ischemia/diagnostic imaging ; Brain Ischemia/surgery ; Thrombectomy/adverse effects ; Thrombectomy/methods ; Brain/diagnostic imaging
    Language English
    Publishing date 2024-02-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2958-0
    ISSN 1538-3598 ; 0254-9077 ; 0002-9955 ; 0098-7484
    ISSN (online) 1538-3598
    ISSN 0254-9077 ; 0002-9955 ; 0098-7484
    DOI 10.1001/jama.2024.0572
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Role of Three-Dimensional Speckle Tracking Echocardiography in the Quantification of Myocardial Iron Overload in Patients with Beta-Thalassemia Major.

    Li, Shu-Juan / Hwang, Yu-Yan / Ha, Shau-Yin / Chan, Godfrey C F / Mok, Amanda S P / Wong, Sophia J / Cheung, Yiu-Fai

    Echocardiography (Mount Kisco, N.Y.)

    2016  Volume 33, Issue 9, Page(s) 1361–1367

    Abstract: ... Results: Compared with controls, patients had significantly lower LV global 3D strain (P < 0.001), twist ... P = 0.01), torsion (P = 0.04), and ejection fraction (P < 0.001) and greater SDI (P < 0.001 ... The GPI was lower in patients than controls (P < 0.001). T2* value correlated positively with global 3D ...

    Abstract Background: The new three-dimensional speckle tracking echocardiography (3DSTE) may enable comprehensive quantification of global left ventricular (LV) myocardial mechanics.
    Methods: Twenty-four patients aged 29.3 ± 5.2 years and 22 controls were studied. 3DSTE was performed to assess LV 3D global strain, twist and torsion, ejection fraction, and systolic dyssynchrony index (SDI). The LV SDI was calculated as % of SD of times-to-peak strain of 16 segments/RR interval. The global performance index (GPI) was calculated as (global 3D strain·torsion)/SDI. Area under the receiver operating characteristic curve (AUC) was calculated to determine the capability of 3DSTE parameters to discriminate between patients with (cardiac magnetic resonance T2* <20 ms) and those without myocardial iron overload.
    Results: Compared with controls, patients had significantly lower LV global 3D strain (P < 0.001), twist (P = 0.01), torsion (P = 0.04), and ejection fraction (P < 0.001) and greater SDI (P < 0.001). The GPI was lower in patients than controls (P < 0.001). T2* value correlated positively with global 3D strain (r = 0.74, P < 0.001) and GPI (r = 0.63, P = 0.001), and negatively with SDI (r = -0.44, P = 0.03). The AUCs of GPI, global 3D strain, ejection fraction, torsion, and 1/SDI were 0.94, 0.90, 0.87, 0.82, and 0.70, respectively. The GPI cutoff of 2.7°/cm had a sensitivity of 94.9% and a specificity of 88.9% of differentiating patients with from those without myocardial iron overload.
    Conclusions: The LV composite index of strain, torsion, and dyssynchrony derived from 3DSTE enables sensitive detection of myocardial iron overload in patients with thalassemia.
    MeSH term(s) Adult ; Echocardiography, Three-Dimensional/methods ; Elasticity Imaging Techniques/methods ; Female ; Humans ; Image Interpretation, Computer-Assisted/methods ; Iron Overload/diagnostic imaging ; Iron Overload/etiology ; Male ; Reproducibility of Results ; Sensitivity and Specificity ; Stroke Volume ; Ventricular Dysfunction, Left/diagnostic imaging ; Ventricular Dysfunction, Left/etiology ; beta-Thalassemia/complications ; beta-Thalassemia/diagnostic imaging
    Language English
    Publishing date 2016-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 843645-9
    ISSN 1540-8175 ; 0742-2822
    ISSN (online) 1540-8175
    ISSN 0742-2822
    DOI 10.1111/echo.13266
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Towards the classification of subpopulations of layer V pyramidal projection neurons.

    Molnár, Zoltán / Cheung, Amanda F P

    Neuroscience research

    2006  Volume 55, Issue 2, Page(s) 105–115

    Abstract: ... genetics identify molecular tags for subtypes of pyramidal cells such as: Otx-1 [Frantz, G.D., Bohner, A.P ... development. J. Neurosci. 14, 472-485; Weimann, J.M., Zhang, Y.A., Levin, M.E., Devine, W.P., Brulet, P ... Gahwiler, B.H., Hornung, J.P., Molnár, Z., 2004. Selective neurofilament (SMI-32, FNP-7 and N200 ...

    Abstract The nature of cerebral cortical circuitry has been increasingly clarified by markers for the identification of precise cell types with specific morphology, connectivity and distinct physiological properties. Molecular markers are not only helpful in dissecting cortical circuitry, but also give insight into the mechanisms of cortical neuronal specification and differentiation. The two principal neuronal types of the cerebral cortex are the pyramidal and GABAergic cells. Pyramidal cells are excitatory and project to distant targets, while GABAergic neurons are mostly inhibitory non-pyramidal interneurons. Reliable markers for specific subtypes of interneurons are available and have been employed in the classification and functional analysis of cortical circuitry. Until recently, cortical pyramidal neurons have been considered a homogeneous class of cells. This concept is now changing as the powerful tools of molecular biology and genetics identify molecular tags for subtypes of pyramidal cells such as: Otx-1 [Frantz, G.D., Bohner, A.P., Akers, R.M., McConnell, S.K., 1994. Regulation of the POU domain gene SCIP during cerebral cortical development. J. Neurosci. 14, 472-485; Weimann, J.M., Zhang, Y.A., Levin, M.E., Devine, W.P., Brulet, P., McConnell, S.K., 1999. Cortical neurons require Otx1 for the refinement of exuberant axonal projections to subcortical targets. Neuron 24, 819-831]; SMI-32, N200 and FNP-7 [Voelker, C.C., Garin, N., Taylor, J.S., Gahwiler, B.H., Hornung, J.P., Molnár, Z., 2004. Selective neurofilament (SMI-32, FNP-7 and N200) expression in subpopulations of layer V pyramidal neurons in vivo and in vitro. Cereb. Cortex 14, 1276-1286]; ER81 [Hevner, R.F., Daza, R.A., Rubenstein, J.L., Stunnenberg, H., Olavarria, J.F., Englund, C., 2003. Beyond laminar fate: toward a molecular classification of cortical projection/pyramidal neurons. Dev. Neurosci. 25 (2-4), 139-151; Yoneshima, H., Yamasaki, S., Voelker, C., Molnár, Z., Christophe, E., Audinat, E., Takemoto, M., Tsuji, S., Fujita, I., Yamamoto, N., 2006. ER81 is expressed in a subpopulation of layer 5 projection neurons in rodent cerebral cortices. Neuroscience, 137, 401-412]; Lmo4 [Bulchand, S., Subramanian, L., Tole, S., 2003. Dynamic spatiotemporal expression of LIM genes and cofactors in the embryonic and postnatal cerebral cortex. Dev. Dyn. 226, 460-469; Arlotta, P., Molyneaux, B.J., Chen, J., Inoue, J., Kominami, R., Macklis, J.D., 2005. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45 (2), 207-221]; CTIP2 [Arlotta, P., Molyneaux, B.J., Chen, J., Inoue, J., Kominami, R., Macklis, J.D., 2005. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45 (2), 207-221]; Fez1 [Molyneaux, B.J., Arlotta, P., Hirata, T., Hibi, M., Macklis, J.D., 2005. Fez1 is required for the birth and specification of corticospinal motor neurons. Neuron 47 (6), 817-831; Chen, B., Schaevitz, L.R., McConnell, S.K., 2005. Fez1 regulates the differentiation and axon targeting of layer 5 subcortical projection neurons in cerebral cortex. Proc. Natl. Acad. Sci. U.S.A. 102 (47), 17184-17189]. These genes outline the numerous subtypes of pyramidal cells and are increasingly refining our previous classifications. They also indicate specific developmental programs operate in cell fate decisions. This review will describe the progress made on the correlation of these markers to each other within a specific subtype of layer V neurons with identified, stereotypic projections. Further work is needed to link these data with observations on somatodendritic morphology and physiological properties. The integrated molecular, anatomical and physiological characterisation of pyramidal neurons will lead to a much better appreciation of functional cortical circuits.
    MeSH term(s) Animals ; Cerebral Cortex/cytology ; Gene Expression/physiology ; Models, Neurological ; Nerve Net/cytology ; Neurons/classification ; Pyramidal Cells/physiology ; gamma-Aminobutyric Acid/metabolism
    Chemical Substances gamma-Aminobutyric Acid (56-12-2)
    Language English
    Publishing date 2006-03-15
    Publishing country Ireland
    Document type Journal Article ; Review
    ZDB-ID 605842-5
    ISSN 1872-8111 ; 0168-0102 ; 0921-8696
    ISSN (online) 1872-8111
    ISSN 0168-0102 ; 0921-8696
    DOI 10.1016/j.neures.2006.02.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top